U.S. patent application number 14/492978 was filed with the patent office on 2015-01-08 for method and apparatus for automated active sterilization of fully implanted devices.
This patent application is currently assigned to TheraNova, LLC. The applicant listed for this patent is TheraNova, LLC. Invention is credited to Daniel R. BURNETT.
Application Number | 20150011928 14/492978 |
Document ID | / |
Family ID | 40351174 |
Filed Date | 2015-01-08 |
United States Patent
Application |
20150011928 |
Kind Code |
A1 |
BURNETT; Daniel R. |
January 8, 2015 |
METHOD AND APPARATUS FOR AUTOMATED ACTIVE STERILIZATION OF FULLY
IMPLANTED DEVICES
Abstract
The current invention provides this advance in infection control
via its unique application of active sterilization to a catheter or
implant. While most catheters, and many implants, are passive
devices, the current invention will provide an active component as
a integral part of the implanted catheter or device to continuously
or intermittently sterilize the exposed surfaces/areas of the
device. This active sterilization may be accomplished by a variety
of mechanisms, including, application of heat, RF, microwave,
ultrasound, ultraviolet radiation or other energy capable of
sterilizing the device or dislodging any problematic Biofilm that
may form. The active sterilization may also employ the pumping of a
sterilizing chemical from all attached drug reservoir, the use of
electricity or freezing temperatures or any other mechanism for
either inhibiting, killing or dislodging any infectious material in
contact with the implant. One major advantage of this design is
that through the use of small, battery powered or inductively
powered sterilization element, the implanted catheter or device can
be effectively sterilized without requiring the standard removal
surgery, waiting period, then replacement of the infected device.
This is expected to translate into greatly improved outcomes
(particularly for devices where infection may be catastrophic, ie a
prosthetic knee or hip), greatly improved costs, and greatly
improved longevity of susceptible devices (ie IV ports, etc.).
Inventors: |
BURNETT; Daniel R.; (San
Francisco, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
TheraNova, LLC |
San Francisco |
CA |
US |
|
|
Assignee: |
TheraNova, LLC
San Francisco
CA
|
Family ID: |
40351174 |
Appl. No.: |
14/492978 |
Filed: |
September 22, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12702977 |
Feb 9, 2010 |
8865063 |
|
|
14492978 |
|
|
|
|
PCT/US2008/073279 |
Aug 15, 2008 |
|
|
|
12702977 |
|
|
|
|
60964822 |
Aug 15, 2007 |
|
|
|
Current U.S.
Class: |
604/21 ;
604/523 |
Current CPC
Class: |
A61L 2/02 20130101; A61L
2/08 20130101; A61F 2/042 20130101; A61L 2/10 20130101; A61M
2025/0056 20130101; A61F 2/82 20130101; A61L 2/18 20130101; A61M
2205/054 20130101; A61M 2205/0205 20130101; A61L 2/12 20130101;
A61M 2205/058 20130101; A61M 25/0017 20130101; A61M 5/142 20130101;
A61L 2/025 20130101; A61M 2205/051 20130101 |
Class at
Publication: |
604/21 ;
604/523 |
International
Class: |
A61M 25/00 20060101
A61M025/00; A61M 5/142 20060101 A61M005/142; A61L 2/02 20060101
A61L002/02 |
Claims
1. A sterilization system for sterilizing, an implanted prosthesis,
comprising a housing sized for implantation within a patient body
and having an energy generator therewithin, wherein the energy
generator is configured to deliver anti-infective energy or agents
through one or more catheters fluidly coupled to the housing.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 121702,977 filed Feb. 9, 2010, which is a
continuation of International Pat. App, Ser. No. PCT/US2008/073279
filed Aug. 15, 2008 which claims the benefit of priority to U.S.
Prov. Pat. App. 60/964,822 filed Aug. 15, 2007, each of which is
incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
[0002] The present invention relates to the field of medical
devices, in particular catheters and other implantable devices in
the body that are susceptible to infection.
BACKGROUND OF THE INVENTION
[0003] In the last few decades, there has been incredible progress
in a variety of medical fields. At the same time, though, many
fields have stymied and remained stagnant. Once such field is the
treatment and prevention of catheter and implant infections.
Despite many of the issues associated with indwelling catheters and
implants, the primary of which is infection in many cases, there
has been little effort put forth to solve these problems and the
medical community at large just accepts these complications as a
fact of life. What effort has been put forth to combat this problem
has been directed at the sterilization of externalized catheters
and devices. These devices typically are highly prone to infection,
but they can be sterilized through the external application of
anti-infective measures. The prior art in this field, then, mostly
consists of devices and methods for sterilizing indwelling
catheters and devices through the external application of
bactericidal measures.
[0004] Fully implantable devices for the prevention of infection,
though, have been limited to bactericidal and bacteriostatic
coatings or the application of a small current/voltage to prevent
bacterial adhesion. The use of an electronegative field to prevent
bacterial adhesion, though, has been in development for quite some
time and there is still no device that has been successfully
commercialized, with this feature due to the energy demands and
poor cost-efficacy. The present innovation, then, provides a fully
implantable novel device and method capable of actively preventing
and treating infection of an indwelling catheter or implant.
SUMMARY OF THE INVENTION
[0005] The current invention provides this advance in infection
control via its unique application of active sterilization to a
catheter or implant. While most catheters, and many implants, are
passive devices, the current invention will provide an active
component as a integral part of the implanted catheter or device to
continuously or intermittently sterilize the exposed surfaces/areas
of the device. This active sterilization may be accomplished by a
variety of mechanisms, including, application of heat. RF,
microwave, ultrasound, ultraviolet radiation or other energy
capable of sterilizing the device or dislodging any problematic
biofilm that may form. The active sterilization may also employ the
pumping of a sterilizing chemical from an attached drug reservoir,
the use of electricity or freezing temperatures or any other
mechanism for either inhibiting, killing or dislodging any
infectious material in contact with the implant. One major
advantage of this design is that through the use of a small,
battery powered or inductively powered sterilization element, the
implanted catheter or device can be effectively sterilized without
requiring the standard removal surgery, waiting period, then
replacement of the infected device. This is expected to translate
into greatly improved outcomes (particularly for devices where
infection may be catastrophic, ie a prosthetic knee or hip),
greatly improved costs, and greatly improved longevity of
susceptible devices tie IV ports. etc.).
[0006] In its preferred catheter (or any device with no moving
parts) embodiment, an ultrasonic energy generator (including
batter, circuit board, etc.) may incorporated into the base of an
intravascular injection port and the port and catheter may be
intermittently subjected to a vigorous ultrasonic wave to break
free any potential biofilm that may have formed in the interim.
This wave may, preferably, be powered b an internal battery and run
on a programmed schedule. The device may also alert the user or
healthcare practitioner that the battery charge is low by simple
vibration or other communication mechanisms. Other sources of
energy may be utilized, as well, including ultraviolet radiation,
temperature extremes (ie freezing/heating), EMF, RF, microwave (or
other energy source) and/or actively pumped drug. In its ideal and
most practical embodiments, the internally powered sterilization
device may also be transcutaneously activated and/or recharged tie
inductive recharging through the use of an external coil providing
pulsed magnetic fields) so that it need not be removed simply due
to battery depletion. This is a critical feature for devices with
long-term implantation and not as essential for devices with
short-term residence. As long-term implants are the most
susceptible to infection, though, these are also the devices that
will need this protection the most, so in its preferred embodiment
the device will incorporate an inductive recharging element The
device may also be capable of communicating to the user the status
of the device and/or usage statistics for the device i.e. number of
times the port has been accessed, pressure inside the port (an
indication of clogging, etc.)
[0007] in its preferred fluid pumping embodiment, the device of the
present invention may entail one or more sterilization features. In
its ideal embodiment, the device of the present invention provides
for an in-line sterilization element capable of sterilizing fluid
that passes through its conduits to prevent spread of infection.
This may entail ultrasonic energy, mechanical energy (i.e. a
rapidly spinning, wire), ultraviolet radiation, temperature
extremes (ie freezing or heating by liquid nitrogen, Peltier
junction, or other means), EMF, RF, microwave (or other energy
source) and/or actively pumped drug. The outside of the conduit may
also be sterilized continuously or intermittently via one or more
of these mechanisms. In its ideal embodiment, the tubing of the
fluid pump may be exposed to an ultraviolet LED that has low
current draw but which is capable of sterilizing stagnant fluid or
low volume flow. This design is optimal when used to prevent
retrograde spread of infection tie when a pump is parked or is in
line with a backcheck valve).
BRIEF DESCRIPTION OF THE DRAWINGS
[0008] FIG. 1--Side view of the catheter sterilizing element.
[0009] FIG. 2--Side view of the fluid flow sterilization with pump
apparatus.
DETAILED DESCRIPTION OF THE INVENTION
[0010] FIG. 1--Side view of the catheter sterilizing element 14. In
this illustration, a modification to a typical subcutaneous
peritoneal port 10 is shown. In this instance, though, the device
is shown equipped with an implanted sterilization element 14
(optionally inductively rechargeable) which contains all the
circuitry, etc. required to provide effective sterilization of the
catheter 12 and/or port 10. In this illustration the sterilization
element is shown as manufactured into the device. In addition the
sterilization element 14 may also be a device which may be coupled
with the implantable device at the time of implantation. In this
illustration, as well, an lima peritoneal catheter 12 is shown
connected to a subcutaneous port 10, but may include: an IV
catheter port, a CNS catheter port, a bladder catheter port, a PICC
catheter, a central venous catheter, etc. There may be elements
within the catheter 12, as well, to transmit energy, etc., for
example, fiberoptics to transmit sterilizing UV or wires to
transmit mechanical, ultrasonic or electrical energy. The devices
illustrated in this Figure may all he inductively rechargeable.
[0011] FIG. 2--Side view of the fluid flow sterilization embodiment
with pump apparatus. In this illustration, the sterilization
element 14 is shown inside of the pump 20 and it may transmit
anti-infective to one or both catheters (e.g., ultrasound) or apply
anti-infective directly to fluid in the pump 20, e.g., UV
sterilization of fluid flow or direct ultrasound to fluid flow or
sterilize the surface of the device itself In this embodiment, as
well, the peritoneal catheter 22 may receive active sterilization
along with the bladder catheter 26 or on its own or indirectly via
the pump 20. The bladder catheter 26 may also receive active
sterilization along with the peritoneal catheter 22 or on its own
or indirectly via the pump 20. Any of the aforementioned
sterilization methods or devices may be used to sterilize the fluid
now and the surface of the device, as well. In this embodiment, the
sterilization element 14 may preferably be inductively rechargeable
as the implantable pump 20, itself, will likely be
rechargeable.
[0012] These are but some of the potential embodiments and should
not restrict the scope of the invention. The invention described
here may be utilized in any implant that requires intermittent or
continuous active sterilization to prevent colonization and/or
spread of infection from the implant. Other devices for which this
technology may be utilized include: pacemakers, Implantable
Cardioverter Defibrillators, CNS shunts, bladder catheters,
suprapubic catheters, cardiovascular valves, mechanical valves,
stents, prosthetic joints (knee, hip, etc), plates, screw or other
orthopedic devices, electrical stimulators, neuromodulators or
other devices.
* * * * *